These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32089824)

  • 1. The development of mouthwashes without anti-gonococcal activity for controlled clinical trials: an in vitro study.
    Van Dijck C; Cuylaerts V; Sollie P; Spychala A; De Baetselier I; Laumen J; Crucitti T; Kenyon C
    F1000Res; 2019; 8():1620. PubMed ID: 32089824
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiseptic mouthwash against pharyngeal
    Chow EP; Howden BP; Walker S; Lee D; Bradshaw CS; Chen MY; Snow A; Cook S; Fehler G; Fairley CK
    Sex Transm Infect; 2017 Mar; 93(2):88-93. PubMed ID: 27998950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial.
    Chow EPF; Williamson DA; Hocking JS; Law MG; Maddaford K; Bradshaw CS; McNulty A; Templeton DJ; Moore R; Murray GL; Danielewski JA; Wigan R; Chen MY; Guy RJ; Zhang L; Donovan B; Grulich AE; Kaldor JM; Whiley DM; Cornelisse VJ; Howden BP; Lewis DA; Read TRH; Fairley CK
    Lancet Infect Dis; 2021 May; 21(5):647-656. PubMed ID: 33676595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol.
    Chow EPF; Walker S; Hocking JS; Bradshaw CS; Chen MY; Tabrizi SN; Howden BP; Law MG; Maddaford K; Read TRH; Lewis DA; Whiley DM; Zhang L; Grulich AE; Kaldor JM; Cornelisse VJ; Phillips S; Donovan B; McNulty AM; Templeton DJ; Roth N; Moore R; Fairley CK
    BMC Infect Dis; 2017 Jun; 17(1):456. PubMed ID: 28659133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Mouthwash on the Oropharyngeal Microbiota of Men Who Have Sex with Men: a Substudy of the OMEGA Trial.
    Plummer EL; Maddaford K; Murray GL; Fairley CK; Pasricha S; Mu A; Bradshaw CS; Williamson DA; Chow EPF
    Microbiol Spectr; 2022 Feb; 10(1):e0175721. PubMed ID: 35019769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
    Van Dijck C; Tsoumanis A; Rotsaert A; Vuylsteke B; Van den Bossche D; Paeleman E; De Baetselier I; Brosius I; Laumen J; Buyze J; Wouters K; Lynen L; Van Esbroeck M; Herssens N; Abdellati S; Declercq S; Reyniers T; Van Herrewege Y; Florence E; Kenyon C
    Lancet Infect Dis; 2021 May; 21(5):657-667. PubMed ID: 33676596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to, and acceptability of, Listerine
    Cornelisse VJ; Fairley CK; Walker S; Young T; Lee D; Chen MY; Bradshaw CS; Chow EPF
    Sex Health; 2016 Oct; 13(5):494-496. PubMed ID: 28636870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neisseria gonorrhoeae Transmission Among Men Who Have Sex With Men: An Anatomical Site-Specific Mathematical Model Evaluating the Potential Preventive Impact of Mouthwash.
    Zhang L; Regan DG; Chow EPF; Gambhir M; Cornelisse V; Grulich A; Ong J; Lewis DA; Hocking J; Fairley CK
    Sex Transm Dis; 2017 Oct; 44(10):586-592. PubMed ID: 28876289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine Mouthwash Fails to Eradicate Oropharyngeal Gonorrhea in a Clinical Pilot Trial (MoNg).
    Van Dijck C; Tsoumanis A; De Hondt A; Cuylaerts V; Laumen J; Van Herrewege Y; Florence E; De Baetselier I; Kenyon C
    Sex Transm Dis; 2022 Feb; 49(2):e38-e41. PubMed ID: 34282741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines.
    Knapp JS; Mesola VP; Neal SW; Wi TE; Tuazon C; Manalastas R; Perine PL; Whittington WL
    Sex Transm Dis; 1997 Jan; 24(1):2-7. PubMed ID: 9018776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of gargling and rinsing among frequent mouthwash users: a cross-sectional study.
    Phillips TR; Fairley C; Maddaford K; Trumpour S; Wigan R; Bradshaw C; Hocking JS; Chow EPF
    BMJ Open; 2020 Sep; 10(9):e040754. PubMed ID: 32994261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential effect of antiseptic mouthwash on the incidence of
    Xu X; Chow EPF; Shen M; Zou Z; Wang C; Ong JJ; Fairley CK; Zhang L
    BMJ Open; 2021 Oct; 11(10):e052823. PubMed ID: 34620667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use and performance of oral-throat rinses to detect pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections.
    Papp JR; Ahrens K; Phillips C; Kent CK; Philip S; Klausner JD
    Diagn Microbiol Infect Dis; 2007 Nov; 59(3):259-64. PubMed ID: 17662554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning for a Gonococcal Vaccine: A Narrative Review of Vaccine Development and Public Health Implications.
    Abara WE; Jerse AE; Hariri S; Kirkcaldy RD
    Sex Transm Dis; 2021 Jul; 48(7):453-457. PubMed ID: 33201019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing resistance of Neisseria gonorrhoeae in west and central Africa. Consequence on therapy of gonococcal infection.
    Van Dyck E; Crabbé F; Nzila N; Bogaerts J; Munyabikali JP; Ghys P; Diallo M; Laga M
    Sex Transm Dis; 1997 Jan; 24(1):32-7. PubMed ID: 9018781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could antiseptic mouthwash inhibit pharyngeal
    Chow EPF; Fairley CK
    Sex Transm Infect; 2017 Sep; 93(6):403. PubMed ID: 28827305
    [No Abstract]   [Full Text] [Related]  

  • 19. Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012-2016.
    Barbee LA; Soge OO; Katz DA; Dombrowski JC; Holmes KK; Golden MR
    Clin Infect Dis; 2018 Feb; 66(5):712-718. PubMed ID: 29045604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome Analysis of Neisseria gonorrhoeae during Natural Infection Reveals Differential Expression of Antibiotic Resistance Determinants between Men and Women.
    Nudel K; McClure R; Moreau M; Briars E; Abrams AJ; Tjaden B; Su XH; Trees D; Rice PA; Massari P; Genco CA
    mSphere; 2018 Aug; 3(3):. PubMed ID: 29950382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.